Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
09/2014
09/03/2014EP2772270A1 Emulsified hydrogel composition and a production method therefor
09/03/2014EP2772257A1 Formulations of quinolinones
09/03/2014EP2772252A1 Oxybutynin-containing transdermal absorption preparation
09/03/2014EP2772251A1 Protamine/RNA nanoparticles for immunostimulation
09/03/2014EP2772250A1 Enteric composition for the manufacture of soft capsule wall
09/03/2014EP2772249A1 Method and composition for treating ocular hypertension and glaucoma
09/03/2014EP2772248A1 Pharmaceutical composition and kit for treating bacterial infections
09/03/2014EP2772247A1 Surface-modified ultraviolet blocking powder and ultraviolet blocking composition including same
09/03/2014EP2772225A1 Ocular therapeutic agent delivery devices and methods for making and using such devices
09/03/2014EP2771033A1 Protein formulations containing amino acids
09/03/2014EP2771023A1 Oral formulations mimetic of roux-en-y gastric bypass actions on the ileal brake; compositions, methods of treatment, diagnostics and systems for treatment of metabolic syndrome manifestations including insulin resistance, fatty liver disease, hyperlipidemia, and t2d
09/03/2014EP2771013A1 Topical pharmaceutical compositions comprising acyclovir
09/03/2014EP2770987A1 Novel compounds that are erk inhibitors
09/03/2014EP2770986A1 Apparatus and method for producing controlled dosage of bioactive agent
09/03/2014EP2770985A1 Artemisinin and berberine compositions and methods of making
09/03/2014EP2770984A1 Device and method for sustained release of therapeutic agent
09/03/2014EP2770983A1 Implantable drug delivery compositions and methods of treatment thereof
09/03/2014EP2770982A1 Implantable rasagiline compositions and methods of treatment thereof
09/03/2014EP2770981A1 Implantable tizanidine compositions and methods of treatment thereof
09/03/2014EP2770980A1 Limit size lipid nanoparticles and related methods
09/03/2014EP2770979A1 Improved cross-linking composition delivered by iontophoresis, useful for the treatment of keratoconus
09/03/2014EP2770978A1 Anti-flush compositions
09/03/2014EP2770977A1 Novel dosage form
09/02/2014US8822675 Low-substituted hydroxypropylcellulose and solid preparation comprising the same
09/02/2014US8822549 Buffered oxygen therapeutic
09/02/2014US8822546 Flowable pharmaceutical depot
09/02/2014US8822493 SNS-595 and methods of using the same
09/02/2014US8822492 Use of huperzine for disorders
09/02/2014US8822489 Abuse deterrent compositions and methods of making same
09/02/2014US8822477 Use of osmolytes obtained from extremophilic bacteria for producing medicine for the external treatment of neurodermatitis
09/02/2014US8822436 Compositions for oral administration of zoledronic acid or related compounds for treating disease
09/02/2014US8822429 Citicoline for the treatment of glaucoma and ocular hypertension
09/02/2014US8822428 Double-stranded RNA oligonucleotides which inhibit tyrosinase expression
09/02/2014US8822423 Affinity peptides toward infliximab
09/02/2014US8822410 Tympanic membrane permeating ear drops and uses thereof
09/02/2014US8822219 Method for preparing biological tissues for use in biological prostheses
09/02/2014US8822156 Methods for rapid identification of pathogens in humans and animals
09/02/2014US8821958 Method for electrostatic coating of a stent
09/02/2014US8821946 Calcium carbonate granulation
09/02/2014US8821944 Polymorph compositions, methods of making, and uses thereof
09/02/2014US8821943 Methods and compositions for targeted delivery of therapeutic agents
09/02/2014US8821942 Highly compressible, low density ground calcium carbonate granulation and a related method of preparation
09/02/2014US8821941 Hair removal with nanoparticles
09/02/2014US8821940 Thermal treatment of the skin surface with nanoparticles
09/02/2014US8821939 Bioactive agent delivery particles
09/02/2014US8821938 Porous drug matrices and methods of manufacture thereof
09/02/2014US8821937 Methods of treating cardiovascular disorders associated with atherosclerosis
09/02/2014US8821936 Solid pharmaceutical formulation
09/02/2014US8821935 Microcapsules with modified release of active principles with low solubility for oral delivery
09/02/2014US8821934 Pullulan-containing powder, process for producing the same and use thereof
09/02/2014US8821933 Polymers and hydrogels
09/02/2014US8821932 Pharmaceutical compositions
09/02/2014US8821931 Micro-particles containing a 3-D polymeric structure
09/02/2014US8821930 Modified release preparations containing oxcarbazepine and derivatives thereof
09/02/2014US8821929 Tamper resistant dosage forms
09/02/2014US8821928 Controlled release pharmaceutical compositions for prolonged effect
09/02/2014US8821927 Pharmaceutical composition
09/02/2014US8821926 Tablet containing hardly soluble active ingredient
09/02/2014US8821925 Ubiquinol and alpha lipoic acid compositions
09/02/2014US8821924 Rhein or diacerein compositions
09/02/2014US8821923 Using bucky paper as a therapeutic aid in medical applications
09/02/2014US8821922 Compositions and methods for polymer-caged liposomes
09/02/2014US8821921 Vitamin D3 for the transdermal treatment of pain and inflammation
09/02/2014US8821920 Therapeutic patch for transdermal delivery of capsaicin
09/02/2014US8821919 Wound debridement
09/02/2014US8821918 Cross-linked gelatin composition comprising a wetting agent
09/02/2014US8821916 Medical dressing comprising an antimicrobial silver compound
09/02/2014US8821914 Non-abusable pharmaceutical composition comprising opioids
09/02/2014US8821913 Controlled releases system containing temozolomide
09/02/2014US8821906 Biocompatible polymer
09/02/2014US8821904 Topical composition and use thereof for the prophylaxis and the treatment of defects connected to inflammatory dermopathies
09/02/2014US8821900 Anti-adhesion material
09/02/2014US8821899 Method and process for the production of multi-coated recognitive and releasing systems
09/02/2014US8821898 Active compound combinations having insecticidal and acaricidal properties
09/02/2014US8821870 Method for treating atrophic age related macular degeneration
09/02/2014US8821859 Methods and articles for the delivery of therapeutic agents
09/02/2014US8821853 Anti-fatty liver agent
09/02/2014US8821849 Internal clamp for surgical procedures
09/02/2014US8821521 Gastro-intestinal device and method for treating addiction
09/02/2014US8821479 Medical device with an energy supply having at least two energy sources
09/02/2014US8821473 Methods and compositions to treat myocardial conditions
09/02/2014US8821457 Punctal plug containing drug formulation
09/02/2014US8821456 Daneshvar medication pads, suppositories and methods
09/02/2014US8821437 Pharmaceutical device for the administration of substances to patients
09/02/2014US8820323 Methods to administer formulations of aminoglycoside and fosfomycin combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
09/02/2014CA2776702C Topical dapsone for the treatment of acne
09/02/2014CA2693644C Chitosan carboxyalkylamide hydrogel, preparation thereof and cosmetic and dermatological use thereof
09/02/2014CA2642952C Pharmaceutical composition comprising oseltamivir phosphate
09/02/2014CA2619744C Formulation having accurate dose-dividing function
08/2014
08/28/2014WO2014130998A1 Surface functionalized porous silicon
08/28/2014WO2014130994A1 Nanoparticles for controlled release of anti-biofilm agents
08/28/2014WO2014130921A1 Particle formulations for delivery of tlr agonists and antigens
08/28/2014WO2014130866A2 Targeted buccal delivery of agents
08/28/2014WO2014130846A1 Transdermal drug delivery using amphiphilic dendron-coil micelles
08/28/2014WO2014130811A1 Interferon beta formulation
08/28/2014WO2014130759A1 Methods of using histamine receptor agonists and antagonists
08/28/2014WO2014130638A1 Combinations of indigo naturalis and berberine and uses thereof
08/28/2014WO2014130488A1 Functionalized nanoparticles for medical treatments
08/28/2014WO2014130432A1 Methods and compositions for improving appearance and formation of scar tissue
08/28/2014WO2014130429A2 Caged platinum nanoclusters for anticancer chemotherapeutics
1 ... 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 ... 2991